Cargando…
PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis
Previous studies have demonstrated the in vitro oncogenic role of protein arginine methyltransferase 5 (PRMT5) in gastric cancer cell lines. The in vivo function of PRMT5 in gastric tumorigenesis, however, is still unexplored. Here, we showed that Prmt5 deletion in mouse gastric epithelium resulted...
Autores principales: | Tang, Yuling, Dong, Lei, Zhang, Chong, Li, Xiubin, Li, Rongyu, Lin, Huisang, Qi, Yini, Tang, Mingchuan, Peng, Yanli, Liu, Chuan, Zhou, Jian, Hou, Ning, Liu, Wenjia, Yang, Guan, Yang, Xiao, Teng, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295066/ https://www.ncbi.nlm.nih.gov/pubmed/35864961 http://dx.doi.org/10.7150/ijbs.71581 |
Ejemplares similares
-
Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway
por: Zhu, Kai, et al.
Publicado: (2020) -
PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression
por: Li, Zhongwei, et al.
Publicado: (2023) -
Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway
por: Li, Mengwei, et al.
Publicado: (2018) -
PRMT5-dependent p53 escape in tumorigenesis
por: Li, Yan, et al.
Publicado: (2015) -
PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway
por: Zhan, Ping, et al.
Publicado: (2017)